The identification of new biomarkers for bladder cancer: A study based on TCGA and GEO datasets

Generation of a multi-functional, target organ-specific, anti-fibrotic molecule by molecular engineering of the extracellular matrix protein, decorin

(2018) Tero A H Järvinen et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cancer statistics, 2018

(2018) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Novel urinary biomarkers for the detection of bladder cancer: A systematic review

(2018) Wei Shen Tan et al.   CANCER TREATMENT REVIEWS

Myofibroblasts in oral potentially malignant disorders: Is it related to malignant transformation?

(2018) RD Coletta et al.   ORAL DISEASES

RCAN1.4 acts as a suppressor of cancer progression and sunitinib resistance in clear cell renal cell carcinoma

(2018) Zhengshuai Song et al.   EXPERIMENTAL CELL RESEARCH

EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer

(2018) Li Wang et al.   Nature Communications

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

(2017) Sebastien Antoni et al.   EUROPEAN UROLOGY

Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review

(2017) Viktor Soukup et al.   EUROPEAN UROLOGY

Unlocking bladder cancer

(2017) Chris Berdik   NATURE

Bladder cancer

(2017) Michelle Grayson   NATURE

Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma

(2017) Xin Ning et al.   OncoTargets and Therapy

Bladder cancer

(2016) Ashish M Kamat et al.   LANCET

The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible

(2016) Damian Szklarczyk et al.   NUCLEIC ACIDS RESEARCH

Measuring the Efficacy and Value of Urothelial Cancer Urinary Biomarkers

(2015) Phillip H. Abbosh et al.   ANNALS OF INTERNAL MEDICINE

Urinary Biomarkers for Diagnosis of Bladder Cancer

(2015) Roger Chou et al.   ANNALS OF INTERNAL MEDICINE

Decorin in human oral cancer: A promising predictive biomarker of S-1 neoadjuvant chemosensitivity

(2015) Atsushi Kasamatsu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Gene expression patterns combined with network analysis identify hub genes associated with bladder cancer

(2015) Dongbin Bi et al.   COMPUTATIONAL BIOLOGY AND CHEMISTRY

Decorin in Human Colon Cancer

(2015) Marie C. Nyman et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

limma powers differential expression analyses for RNA-sequencing and microarray studies

(2015) Matthew E. Ritchie et al.   NUCLEIC ACIDS RESEARCH

DCN deficiency promotes renal cell carcinoma growth and metastasis through downregulation of P21 and E-cadherin

(2015) Yongcan Xu et al.   TUMOR BIOLOGY

Decorin Suppresses Prostate Tumor Growth through Inhibition of Epidermal Growth Factor and Androgen Receptor Pathways

(2015) Yunping Hu et al.   NEOPLASIA

Decorin is responsible for progression of non-small-cell lung cancer by promoting cell proliferation and metastasis

(2014) Xuefei Shi et al.   TUMOR BIOLOGY

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

(2013) Marko Babjuk et al.   EUROPEAN UROLOGY

Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation

(2012) Thomas Reinert et al.   PLoS One

Bladder Cancer in 2010: How Far have We Come?

(2010) B. L. Jacobs et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples

(2010) V. L. Costa et al.   CLINICAL CANCER RESEARCH

TGF-β-induced epithelial to mesenchymal transition

(2009) Jian Xu et al.   CELL RESEARCH

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

(2009) Bas W.G. van Rhijn et al.   EUROPEAN UROLOGY

Transforming Growth Factor- 1, Transforming Growth Factor- 2, and Transforming Growth Factor- 3 Enhance Ovarian Cancer Metastatic Potential by Inducing a Smad3-Dependent Epithelial-to-Mesenchymal Transition

(2008) T.-V. Do et al.   MOLECULAR CANCER RESEARCH

Unregulated smooth-muscle myosin in human intestinal neoplasia

(2008) P. Alhopuro et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA